Reaction
Steatorrhoea reporting signals
As of the last recalculation, Steatorrhoea appears in 2,642 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is ORLISTAT (PRR 1,332.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Orlistat | 1,649 | 1,332.6 | 1,423.6 |
| Pancrelipase | 314 | 72.6 | 73.2 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 34 | 21.7 | 21.8 |
| Lanreotide Acetate | 20 | 20.2 | 20.3 |
| Octreotide Acetate | 72 | 19.0 | 19.1 |
| Lumacaftor And Ivacaftor | 19 | 17.6 | 17.6 |
| Dornase Alfa | 40 | 16.3 | 16.3 |
| Tobramycin Sulfate | 11 | 7.0 | 7.0 |
| Tobramycin | 20 | 6.6 | 6.6 |
| Tobramycin Solution | 10 | 6.6 | 6.6 |
| Ursosiol | 15 | 6.1 | 6.1 |
| Ursodiol | 15 | 5.5 | 5.5 |
| Acetaminophen And Codeine | 6 | 3.9 | 3.9 |
| Ivacaftor | 3 | 3.0 | 3.0 |